ARM can turn its entrenched CPU architecture into a larger AI-compute franchise, with royalties and in-house silicon amplifying one another.
ARM’s opportunity is real, but constrained supply, mobile exposure, execution uncertainty, and a premium valuation leave little room for disappointment.
Licensing remains healthy, with 25–30% growth in FY27 as customers convert to subscriptions.
Royalties are expected to reaccelerate in FY28 as Cloud AI grows its share of the royalty mix.
Management has become incrementally confident in a significant AGI CPU backlog, creating potential for an early guide update.
StoneX sees strong demand for ARM’s AGI CPUs, but foundry capacity remains the binding constraint, limiting FY28 CPU revenue to ~$8.0B vs. Street ~$8.3B and leaving META as the only signed customer until ARM secures more advanced-node supply. Licensing rema...
StoneX sees strong demand for AGI CPUs, but foundry capacity remains the binding constraint, limiting FY28 CPU revenue below Street estimates.
The company has limited near-term upside at its current valuation of over 100x NTM non-GAAP EPS.
Wells Fargo expects limited near-term estimate revisions, with data-center strength partly offset by smartphone weakness.
Valuation remains demanding.
Foundry supply constraints are expected to cap the company's FY28 CPU revenue below Street estimates.
Evercore estimates the company is capturing approximately half of new hyperscale CPU deployments.
AMD +3.4% as Evercore’s checks with 20+ AI engineers found agentic fan-out pushing server CPU:GPU ratios from one per 2-4 GPUs toward 1:1, with CPU ASPs up 10-15% q/q in 1H26 and seen up 15-20% in 2H26 (one expert models 20-25% through 2027 until CoWoS ease...
QCOM/ARM: Qualcomm wins 2 of 3 claims; $2 damages mask more meaningful legal/equitable upside
A jury found ARM breached QCOM’s ALA by withholding required deliverables and intentionally interfered with its Meta relationship, while ARM won the TLA/MFN pricing claim. The $2 award is nominal because QCOM’s ~$1.7B damages theory relied on §8.3, which th...
QCOM +1.4% (+3.6% at the highs) after a jury found ARM breached its license agreement; ARM +6bps, -4.6% at the lows, shrugged it off. As bretzel understands it in Slack here, the jury ruled on one portion of damages; the bench decision on contract reme...
The company is currently involved in a five-day jury trial in Delaware where Qualcomm is seeking up to five years of royalty relief, with the judge considering whether to strike that remedy.
The company is currently in a five-day jury trial in Delaware against QCOM, which is seeking up to five years of royalty relief, with the judge considering whether to strike that remedy.
CPU names split: ARM +3.6% and INTC/AMD flat
The stock closed near its lows, giving back some of its recent outperformance, with no clear reason other than potential over-excitement around the impact of MUSE and consumer agentic apps.
AMD +2.4% / INTC +3.9% reversed hard off the morning lows (INTC closed at the highs), shrugging off the M-sci shipment datapoint on AMD we flagged this morning. KeyBanc’s bus-tour note helped INTC (14A “~1 year ahead of where 18A was”), and NBIS told custom...
The stock was a standout winner, playing catch-up to AMD after its CEO provided an optimistic update last week, with expectations for continued strength.
The company is expected to benefit from increased demand for CPU chips, particularly as hyperscalers, which largely use ARM-powered chips, become beneficiaries if OpenAI's consumer agentic product gains traction.
ARM +17% the standout winner today, playing catch up to AMD after CEO up ticked last week. Some more color from our weekly yesterday: “If OpenAI announces their own consumer agentic product, we think there might be some slight near-term “narrative” shift in...
The CEO expressed more confidence in securing supply to meet $2 billion of demand for its AGI CPU compared to July.
Manufacturing capacity, rather than demand, remains the key constraint.
The AGI CPU program is on track, with Meta expected to be a major contributor to the initial revenue opportunity, and final qualification underway for first shipments in CQ1 2027.
Underlying demand for the AGI CPU program already exceeds the initial FY28 target, and ARM is expected to surpass the original target once TSMC capacity becomes available, with improved visibility by next March.
TSMC remains the only viable manufacturing partner for ARM's first in-house chip, and likely for the second-generation 2nm product as well, indicating a strong and stable manufacturing relationship.
Bernstein reported that the AGI CPU program is on track, with demand already exceeding $2 billion against an initial $1 billion FY28 target.
Piper initiated coverage with an Overweight rating and a $320 price target, anticipating server CPU design wins across hyperscalers and custom silicon.
Piper believes ARM is benefiting from hyperscalers increasingly adopting in-house Arm-based server CPUs, with further upside from new custom silicon wins such as Meta.
Piper also points to collaborations with SoftBank-affiliated Graphcore and Ampere on a GPU-like accelerator, suggesting ARM's opportunity extends beyond CPUs into a broader share of AI compute silicon.
William Blair reiterated Outperform, noting that improving TSMC 3nm allocation, customer mix, and potential pricing could support upside to the company's first-generation AI CPU opportunity.
William Blair highlighted that cloud AI now represents a significant portion of royalties, with infrastructure royalties more than doubling year-over-year for a second consecutive quarter, driven by major cloud providers.
William Blair also pointed to licensing growth above 25%, expanding Arm Total Access adoption, and increasing CPU attach rates in future AI systems as positive factors.
Weaker smartphone demand remains the main offset to positive trends.
The stock was a significant mover in AI semis, indicating strong positive momentum.
ARM is transitioning from a smartphone-centric IP royalty business to a dominant CPU platform across various AI and computing domains.
The economic model is strengthened by customers licensing architecture and subsystems, followed by royalties, and now the ability to capture more content by selling complete AGI CPU silicon.
New technologies like v9 and CSS are increasing royalty rates and the number of cores monetized per chip, while data center deployments are growing significantly.
AGI demand exceeded expectations, initial products reached multiple customers, and supply for the initial opportunity was secured, with increased confidence in obtaining incremental capacity.
Licensing growth accelerated even after the move into silicon, suggesting customers do not view ARM's AGI CPU as a major conflict with the IP model.
Cloud AI continued to outperform, and hyperscaler partners are increasing deployment velocity, providing a path to royalty upside despite smartphone weakness.
Agentic AI is expected to significantly increase CPU intensity, potentially expanding the AI CPU TAM and allowing ARM to capture a substantial share through its own silicon and royalties.
The quality of the near-term outlook is mixed, with total revenue and EPS guidance beating expectations but royalties significantly below, offset by licensing.
Royalties are recurring and high-margin, while licensing is deal-timing-dependent and includes a significant contribution from SoftBank.
Smartphone weakness is extending beyond lower-end devices, and mobile still constitutes the majority of royalty revenue.
The operating expense beat was due to timing rather than a structural reduction in investment.
Despite impressive AGI demand, the company did not raise its revenue opportunity, and supply chain constraints remain a challenge for a new silicon supplier.
The initial gross margin for AGI CPUs is significantly lower than the IP revenue, leading to mix dilution as silicon revenue grows.
Structural execution and competition risks exist from x86, RISC-V, hyperscaler-designed CPUs, and other accelerator vendors.
The decision to stop disclosing RPO and customer-access counts reduces visibility into the durability of licensing strength.
A large total addressable market does not guarantee ARM's chip share, average selling price, or operating margin.
The company is positioned as a key technology and memory enabler in the AI data center market.
The firm’s preferred tactical ideas are AMAT, AMD, and ON, citing upside from server CPU demand, AI infrastructure spending, and analog pricing, while remaining cautious on KLAC, ARM, and Qorvo due to tougher near-term setups. Goldman also expects continued...
Goldman Sachs remains cautious on ARM due to tougher near-term setups.
Bernstein argues that the shift to agentic AI fundamentally changes data-center architecture, making CPUs increasingly critical for various functions and expanding the server CPU TAM.
Bernstein raises its 2030 server CPU TAM forecast significantly, with its prior forecast now representing the bear case, and believes CPU-to-GPU ratios could move toward 1:1 as inference workloads become more iterative.
Bernstein sees Arm as the primary beneficiary of the expanded CPU TAM due to its power-efficiency advantages and growing hyperscaler adoption.
Bernstein argues that investors are underestimating Arm's ability to capture value through rising royalty rates and its new AGI CPU business, forecasting AGI CPU revenue to reach $22B by FY31.
Bernstein expects cloud royalty revenue to grow significantly as hyperscalers adopt higher-core-count CPUs and migrate toward higher-value CSS designs.
(MU/SNDK +2-3%; INTC/AMD/ARM +2-3%).
The shift from chatbot AI to agentic AI fundamentally changes data-center architecture, making CPUs increasingly critical for orchestration, memory management, networking, and agent coordination.
The company benefits from CPU tailwinds and exposure to Vera/Trainium.
We laid out some ARM short to hedge against our other CPU longs. We usually stay away from this stock both long and short unless it’s a tactical trade if the chart gives us an opportunity. No strong bias either way — we like the CPU tailwinds & the Vera/Tra...
The company's numbers and valuation do not make much sense, especially when compared to AMD.
The company's stock was softer, indicating a weaker performance compared to other semiconductor names.
In Techlandia, strength in semis continues although more bifurcated this morning with HDDs/Memory leading us higher (WDC/STX +8-10%) and SNDK/MU +2-3% while CPU names softer (ARM -2%, INTC -1% although AMD +50bps)
The stock was weaker, consistent with other CPU plays, suggesting a broader market move rather than being solely driven by specific company news.
other CPU plays weaker as well which points to move today being something other than the M-sci datapoint:INTC -8%; ARM -4%
BofA remains constructive on ARM due to the expansion of the server CPU TAM driven by agentic AI.
CPUs/AMD/ARM: BofA Raises Server CPU TAM to $170B, Says Agentic AI Fundamentally Expands the Opportunity
Against this backdrop, BofA raised targets across CPU-exposed names, double-upgraded INTC to Buy, remains constructive on AMD and ARM, and continues to view
The company's stock price increased following BofA's upgrade of INTC, which also talked up CPUs.
Mizuho also highlighted ARM’s emerging AI ASIC opportunity and noted that growing TPU, OpenAI, and MTIA deployments are incrementally positive for memory and storage demand, reinforcing its bullish view on MU, SNDK, STX, and WDC.
ARM +1% the one I hear most about valuation/number disconnect from the opposite view: basically stock discounting a significant earnings jump and investors using per core royalty numbers that are way too high for NVDA, where its prob 10-15c, not 50c.
There's a significant valuation/number disconnect, with the stock discounting a substantial earnings jump. Investors are using per-core royalty numbers that are considered too high for NVDA, estimated at 10-15 cents rather than 50 cents.
The CFO reiterated the $15 billion/$9 EPS target, indicating strong demand, though the company is facing supply constraints due to DRAM.
While ARM should benefit from higher CPU adoption through royalties, the firm cautions that Nvidia’s growing CPU presence could create some double-counting risk around ARM’s standalone AI CPU opportunity. The analyst views the updates as supportive of NVDA’...
The company's stock price increased significantly following NVIDIA's announcement of a new RTX chip, indicating positive market reaction.
Feedback for the company's architecture is stepping up due to x86 shortage and strong Vera feedback, suggesting increasing adoption and demand.
AMD/INTC: Hearing Clev positive raising numbers saying CY26 CPU now +20% y/y as both continue to raise price. Also saying ARM feedback stepping up due to x86 shortage & strong Verea feedback
The stock saw a significant increase despite expectations for a competing announcement from NVIDIA, indicating strong positive sentiment.
Still, broadly speaking, AI semis price action continues to be full HOT AI SUMMER, with right tail outcomes more prevalent than left tail. Just check out ARM +15% despite many expecting the NVDA RTX Spark announcement at Computex. Even NVDA +6% beginning to...
Memory: Mizuho Raises PTs Across MU/SNDK/ARM/DELL/ON on Agentic AI + HBM Tightness
AMD/ARM/NVDA/INTC: Wolfe Sees AI CPU TAM Driving ~30% CPU Market Growth Through CY28, AMD Biggest Beneficiary
ARM is also seen as a major winner through both higher CPU share and royalty leverage, while NVDA is expected to capture the largest absolute AI CPU share but with a more modest EPS impact given the scale of its GPU business.
The company's stock received a bid in anticipation of Computex CPU announcements next week.
The stock was weaker following Softbank overnight.
The company's stock performed well as part of the CPU trade.
NVIDIA's commentary on significant standalone Vera CPU revenue is a strong positive indicator for ARM's royalty and AGI CPU opportunities.
The Vera-Rubin cycle, along with Graviton and Axion deployments, is expected to drive ARM's hyperscaler CPU share gains beyond 50% and increase demand for ARM's AGI CPU roadmap.
ARM's current AGI CPU revenue targets may be conservative given the accelerating agentic AI workloads and increasing CPU intensity in AI infrastructure.
Jefferies says NVDA’s commentary around ~$20B of standalone Vera CPU revenue this year is a strong positive read-through for ARM’s royalty and AGI CPU opportunity. The firm believes the Vera-Rubin cycle, alongside Graviton and Axion deployments, should cont...
The firm forecasts global server CPU units growing from ~23M in 2025 to ~63-70M by 2030 (~30% CAGR), with ARM share rising from 16% to 42% and AMD from 24% to 29%, while Intel declines from 60% to 29%.
In terms of read-throughs, positive for ARM although we don’t know the actual #s from licensing deal with Vera. The $200B TAM is > than the $125B Lisa Su threw out on AMD’s EPS call, but AMD -2% down on concerns of share loss (INTC -3% down
The stock broke out to new highs, indicating strong market momentum.
The company is expected to be the fastest share gainer overall in the CPU market, driven by both merchant and custom/ASIC ARM solutions.
ARM architecture is anticipated to become more prevalent in agentic AI applications.
ARM architecture is going to be more common in agentic AI BUT it doesn't 1) participate in pricing upside 2) own CPU is multiple years away and creates a conflict of interest with licensors 3) significant mobile phone exposure frontloaded 4) even if ARM hit...
The company does not participate in pricing upside, limiting its revenue potential.
The company's own CPU development is multiple years away and could create conflicts of interest with its licensors.
The company has significant mobile phone exposure, which is front-loaded and could present future challenges.
Even if the company meets its CPU targets, the valuation upside is considered modest.
Bernstein initiated coverage with an Outperform rating and a $300 price target, arguing that Agentic AI is driving a major structural increase in CPU demand as orchestration-heavy workloads push CPU-to-GPU ratios from 1:8 toward 1:1.
Bernstein believes ARM's power efficiency and growing hyperscaler/server CPU penetration position it as a primary beneficiary of this 'CPU renaissance,' forecasting Arm CPU TAM expanding toward $137B by 2030.
Bernstein sees ARM evolving from a pure IP licensor into a broader compute platform company spanning Cloud AI, Edge AI, and Physical AI workloads.
Bernstein argued that ARM's Neoverse architecture is winning because the new bottleneck is efficient orchestration under power and space constraints, rather than just peak performance.
The industry, including Microsoft Cobalt, NVIDIA Grace, and AWS Graviton, uses ARM cores, with AWS stating Graviton delivers up to 40% better price-performance versus x86, 20% lower cost, and up to 60% lower energy consumption on equivalent workloads.
Checks on Graviton continue to sound very positive, reinforcing the analyst's positive view on ARM's exposure there.
Bloomberg reported that Arm Holdings Plc is facing an antitrust investigation by the US FTC over its licensing of semiconductor technology, probing whether Arm is trying to illegally monopolize parts of the semiconductor market.
The FTC is investigating whether Arm will refuse or lower the quality of licenses for blueprints to develop central processing units while ramping up efforts to develop its own chips.
Re: power efficiency, Bernstein makes the argument that ARM’s Neoverse architecture wins bc the new bottleneck is efficient orchestration under power and space constraints, not just peak performance — for example, AWS states Graviton (built on Neoverse) del...
Explosive demand for its power-efficient AGI CPU platform, driving massive projected revenue growth.
Near-term headwinds in the smartphone market.
CPUs: UBS Says Server Demand Remains Strong While AMD/ARM Continue Taking Share from INTC
The firm highlights strong server CPU demand trends from AMD and Intel, with hyperscalers accelerating AI capex and internal ARM CPU deployments (Graviton/Cobalt/Axion) further validating the broader CPU opportunity.
Despite the upside potential, BofA reiterates Underperform, arguing much of the opportunity is already reflected and preferring AMD/ARM as better-positioned CPU beneficiaries.
The print did not shake the conviction of CPU bulls, despite the stock's decline.
We’ll wait until the weekend to dive further into the question when we go through the universe of charts, but on the margins some price action tea leaves less positive than the euphoric action earlier in the week, which is to be expected: not everything can...
The company's numbers missed expectations, particularly given heightened expectations.
Supply issues, specifically a lack of additional TSMC 3nm wafer allocation for the current calendar year, were cited as a gating constraint.
The former weighted down by ARM/COHR misses and the latter helped by DDOG/FTNT’s better prints, giving software bulls hope that there is alpha to be had in the space and that a good print will be rewarded with a good move. However, DDOG and FTNT different t...
The stock increased significantly after earnings, indicating positive investor sentiment despite mixed results.
Licensing revenue exceeded expectations, compensating for a miss in royalty revenue.
The company raised its AI CPU orders guidance for future fiscal years, more than doubling its previous estimate.
The launch of their AGI CPU for data centers with Meta as a lead partner demonstrates strong customer demand and progress towards long-term forecasts.
The platform expansion is supported by over 50 leading companies, indicating broad industry adoption and confidence.
The stock rose in sympathy with AMD's positive performance and bullish outlook on CPUs.
ARM +7% numbers mixed and some head scratching in conversations about why stock up 7% after being up 13% today. Licensing beat offsetting royalty with the guide largely in-line. Expects had been very high here following INTC/AMD and bulls want to hear simil...
All in all, didn’t hear much pushback from investors with bulls now looking for close to $23 in EPS in ‘28 and close to $30 in 2030 and saying co deserves a higher multiple than 20x+.ARM +13% and INTC +4.5% in sympathy, with all hitting new highs.
Royalty revenue missed Street expectations.
The stock's initial post-earnings surge faded, suggesting some investor skepticism or profit-taking.
UBS continues to see ARM as the biggest beneficiary (+24% potential EPS impact), followed by AMD (11%) and then INTC (7%), with near-term demand broadly supportive but longer-term differentiation emerging as workloads mature.
Google's TPUv8 reinforces strong attach for ARM-based CPUs and increasing HBM/SRAM content, driving upside across ARM.
AVGO/ARM/MU/CRDO/LITE: Mizuho Highlights TPUv8 as Catalyst for Networking and Memory Upside
The firm says GOOGL’s TPUv8 reinforces strong attach for ARM-based CPUs and increasing HBM/SRAM content, driving upside across AVGO, ARM, and MU. The analyst notes architectural shifts (boardfly topology, OCS, Axion CPUs) improve bandwidth and reduce latenc...
The stock experienced a significant decline, and the analyst did not find clear reasons or answers for this weakness.
AMD remains a strong x86 competitor, and ARM-based options from NVIDIA, AWS and Google create a medium-term share risk.
Semis: GS 1Q Preview; Broad Upside — Long AMAT, TER, AMD; Cautious KLAC, ON, ARM AMAT TER AMD KLAC ON ARM
Goldman Sachs recommends tactical shorts due to near-term smartphone weakness, despite a constructive long-term pivot.
The entry into chip-making is strategically sound, aligning with agentic AI and reinforcing the relevance of CPUs in power-efficient computing.
Arm is intensifying competition in cloud AI CPUs through three strategies: its standard AGI CPU, custom ASICs from hyperscalers, and direct competition with x86 reference platforms.
Arm CPU penetration is expected to rise rapidly starting in H2 2026, driven by superior performance-per-watt efficiency and lower deployment costs compared to x86 incumbents.
The expanded product portfolio addresses a historical gap in Arm's offerings, positioning the architecture as a mainstream cloud alternative as customers prioritize supply chain diversification in AI infrastructure.
The stock was downgraded due to a slow commercial ramp, DRAM shortages impacting client royalties, margin pressure from increased R&D ahead of meaningful chip revenue, and potential channel conflict with licensees.
The bull case is constrained by three hurdles: normalization of DRAM supply, the outcome of Qualcomm litigation, and the strategic behavior of licensees.
Wells Fargo raised its price target to $175 after management meetings, becoming more confident in the AGI CPU's competitive position and 3nm supply.
The AGI's 300W TDP delivers twice the performance per rack compared to x86 CPUs at 400-600W, potentially saving an estimated $10 billion in capex per GW of AI data center capacity.
Arm is confident in its 3nm TSMC allocation via Socionext, with die-to-wafer analysis suggesting future requirements represent less than 5% of TSMC’s 3nm capacity.
Wells Fargo also noted an emerging accelerator/XPU royalty opportunity with a key customer that could become a compelling story in fiscal years 2028/2029.
The company's historic shift from pure IP licensing to designing and selling its own chips, starting with a custom processor for Meta, positions it to enter the fabless chip market.
CPUs are critical to AI infrastructure for token distribution and orchestration, positioning Arm's energy-efficient processors to complement Nvidia's offerings in data center deployments.
Agentic AI is expected to drive a step function increase in CPU core demand, with the efficiency of the core being as important as performance, potentially leading to implementations with 256 or 512 cores.
Needham upgraded ARM to Buy, citing its push into silicon, higher royalty rates, and expansion into subsystems as paying off and repositioning the company as a credible AI play.
The new AGI CPU launch, targeting hyperscale and enterprise workloads with strong early customer traction, marks a key step into the silicon market.
Near-term COT risk from hyperscalers is mitigated by multi-year contracts and execution challenges in in-house chip design, supporting limited risk over the next 2–3 years.
The firm sees a path to ~$15B in silicon revenue by CY30 with margins expanding to 50%+, underpinning ~$9 EPS potential as ARM transitions to full COT.
The company faces execution risks including supply chain constraints, particularly memory bandwidth, and operational challenges new to its business model.
Memory is quite challenging and could limit how big the business can get, with HBM being a capacity hog and the explosion of CPU demand driving up memory demand.
The company is shifting towards a fabless semiconductor model and introducing its internally developed AGI CPU, which targets agentic AI workloads with higher bandwidth and performance, positioning it as a more direct participant in AI infrastructure.
Updated guidance implies significant incremental revenue by FY28 and FY31, with royalties growing at a strong CAGR, supporting a meaningful step-up in EPS.
The company's entry into the server CPU market is a key beneficiary of agentic AI, with its CPU architecture well-suited for inference workloads, positioning it as a potential "orchestrator" layer.
The company's ecosystem and royalty model support durable CAGR growth, with agentic AI driving higher CPU attach rates and long-term earnings power.
There is incremental upside from its new merchant "AGI CPU" and expanding Total Addressable Market, with strong early customer interest.
The firm notes the chip—co-developed with META—targets agentic AI workloads with higher bandwidth and performance, positioning ARM as a more direct participant in AI infrastructure.
The FY31 EPS targets are ambitious compared to the firm's base case.
Risks remain around competition, unit share, and smartphone/server demand, requiring strong execution to justify long-term upside.
HSBC upgraded the stock to Buy and raised its price target, citing an underappreciated shift towards AI server CPUs.
Upcoming product disclosures at the Arm Everywhere event are seen as a catalyst, with hyperscaler adoption driving higher royalty rates and expanding the total addressable market.
Server CPU royalties are projected to grow significantly, supported by merchant CPU offerings and higher average selling prices, which could lead to a re-rating.
The company is competing aggressively across CPU/DPU/XPU programs, with potential custom engagements with OpenAI and Meta.
BofA reiterated a Neutral rating and raised its price target, lifting its CPU share outlook due to the pivot toward an in-house merchant CPU model.
The full silicon strategy is expected to significantly expand its serviceable addressable market and operating margin opportunity compared to the IP-only model.
BofA flagged the risk of losing significant annual licensing revenue from SoftBank, requiring substantial chip sales to offset, which limits near-term conviction despite structural upside.
BofA downgraded the stock to Neutral, seeing royalty and licensing growth slowing into CY26, driven by the company's approximately 80% consumer exposure as smartphone units are expected to decline low-single-digit year-over-year on higher memory costs, with PCs flat to down and infrastructure still approximately 12% of royalties.
The firm expects licensing revenue to fall approximately 5% year-over-year excluding SoftBank, noting SoftBank now represents approximately 25-30% of licensing and is increasingly masking weaker underlying demand, raising circularity concerns.
With v9 transitions largely complete and CSS monetization still early, BofA sees limited near-term mix upside despite longer-term data center opportunity.
Keybanc was also negative, stating that higher memory pricing and shortages represent a headwind to the company's royalty outlook, as the smartphone market is expected to contract in 2026.
The company has reorganized to create a Physical AI unit, expanding its presence in the robotics market, which is a theme at CES.
BofA cuts INTC to Underperform from Neutral, maintaining a $34 PO, saying the stock’s $80B run now fully prices in balance-sheet improvement and foundry optionality. The firm argues INTC still lacks a competitive AI roadmap and continues losing CPU share to...
Q4 revenues beat street expectations
Q1 revenue guidance is ahead of street expectations
Gross margins for both Q4 and Q1 are holding steady and meeting street expectations
Growing investor interest in custom in-house chip designs and long-term transformative licensing opportunities.
NVDA +1.9% JT MS Asia analyst outjust now saying Wistron seeing ~7% raise to their GBZOO rack orders TSM -1% likely on the SamsungITSLA foundry deal although we think that says more about TSM being supply constrained than any mfg advantage Sammy might have...
Near-term FY27 EPS and revenue forecasts were lowered, and the Ampere deal may face delays.
Research through 2026-10-26 · 2025-07-28 to 2026-10-26 · 61 source reports.
| Range | Prices through |
|---|---|
| 1W | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | |
| 2Y | |
| 3Y |
Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.